Skip to main content

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases

Corticosteroids to Treat Pancreatitis

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Corticosteroids to Treat Pancreatitis

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema

Implementation and Effectiveness Trial of HN-STAR

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Implementation and Effectiveness Trial of HN-STAR

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • …
  • Next page Next
  • Last page Last
Subscribe to